Your browser doesn't support javascript.
loading
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
Pivot, X; Awada, A; Gedouin, D; Kerger, J; Rolland, F; Cupissol, D; Caponigro, F; Comella, G; Lopez-Pousa, J J; Guardiola, E; Giroux, B; Gérard, B; Schneider, M.
Affiliation
  • Pivot X; Service d'Oncology, CHU J. Minjoz, Besançon, France. xpivot@chu-besancon.fr
Ann Oncol ; 14(3): 373-7, 2003 Mar.
Article in En | MEDLINE | ID: mdl-12598340
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carbazoles / Methotrexate / Head and Neck Neoplasms / Neoplasm Recurrence, Local / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carbazoles / Methotrexate / Head and Neck Neoplasms / Neoplasm Recurrence, Local / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: